Breast Cancer News of Note: August 2022

August 9, 2022

As an organization that serves young women affected by breast cancer, we make sure to keep up with the latest news so we know what our women face when it comes to treatment and beyond. In this blog series, we will share the the month’s news that we feel is most interesting and relevant.

Here are the headlines from August 2022 (we will continue to update this post through the end of the month)

August 2: "Why Racial Diversity Matters in Breast Cancer Clinical Trials" Read the full article from Healthline HERE.

August 5: "FDA Approves First Targeted Therapy for HER2-Low Breast Cancer" Read the full article from the FDA HERE.

August 8: "FDA Approves First Targeted Therapy for HER2-Low Breast Cancer" Read the full article from Healthline HERE.

August 15: "Flu Season Could Start Early: When's the Best Time to Get Your Shot?" Read the full article from Healthline HERE.

August 17: "New study indicates people with current cancer diagnosis may face severe complications from COVID-19" Read the full article from Medical Xpress HERE.

August 19: "Efficacy of durvalumab for early-stage triple-negative breast cancer examined by race" Read the full article from Medical Xpress HERE.

August 22: "Celebrating 10 Years of Global Research with Breast Cancer Now Tissue Bank" Read the full article from News-Medical HERE.

August 22: "Want to Maintain Muscle?  Frequency of Workouts Is Key" Read the full article from HealthDay HERE.

Archives

Archives

Recent Post

© 2024 Here for the Girls, Inc. is a 501(c)(3) public charity
EIN 26-0606190
1309 Jamestown Rd. Suite 204
Williamsburg, VA 23185
Contact us at info@hereforthegirls.org or at 757-645-2649

‌⁠If you are in a life-threatening situation, please do not use this website. Please use the list below for resources or call 911 to request crisis intervention, or other appropriate personnel, for immediate support. National Suicide Prevention Lifeline – Call 800-273-TALK (8255) Crisis Text Line – Text NAMI to 741-741
cross linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram